Alpha Cancer Technologies Inc - Company Review
Alpha Cancer Technologies Inc - Company ReviewSummary
Alpha Cancer Technologies Inc (ACT) is a biotechnology company that provides development in oncology and auto-immune disease indications. The company products include alpha fetoprotein, immunology platform and targeted chemotherapy platform. It manufactures products using its proprietary recombinant human alpha fetoprotein with unique immuno-oncology properties. ACT include drug master file with FDA manufacturing, toxicology and human safety. The company provides treatment of myasthenia gravis, multiple sclerosis and autoimmune encephalitis and lupus. It also include chemotherapy platform for the treatment of solid and liquid tumors. The company collaborates with healthcare university, cancer and polytherics institution. ACT is headquartered in Toronto, Ontario, Canada.
This comprehensive company report of Alpha Cancer Technologies Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.